GE HealthCare realigns IGT to AVS segment; recasts 2022-2024 segment revenue and EBIT

GE HealthCare Technologies Inc.

Effective July 1, 2024, Image Guided Therapies moved from Imaging to Ultrasound, renamed Advanced Visualization Solutions (AVS).
Recast Q2 2024 Imaging revenue $2,171M; AVS revenue $1,249M (Procedural Guidance $668M, Specialized Ultrasound $581M).
Recast Q2 2024 Segment EBIT: Imaging $208M, AVS $255M, PCS $78M, PDx $200M.
Total revenue and EBIT unchanged; company now reports four segments: Imaging, AVS, PCS, PDx.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.